Highlights of an evidence-based review offer practical guidance for effective depression screening and assessment strategies for primary care physicians.
Meta-Analysis Finds High Uptake but Moderate Adherence in Clinical Trials of Depression and Anxiety Apps
Mental health apps show high initial uptake but moderate adherence, revealing key factors for improving user retention in clinical trials.
Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and Cardiovascular Outcomes
Today's episode covers depression risk after chronic illness, vaginal estradiol safety, GLP-1 updates, cancer risk, and cardiovascular outcomes.
Atopic Dermatitis Signs and Symptoms for Referral: Physical and Emotional Expertise
Primary care is the ideal setting for management of atopic dermatitis, but certain scenarios, both physical and psychological, call for expert referral.
The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression
Insights on atopic dermatitis treatment preferences, the safety of childhood vaccines, maternal depression’s effect on parenting, and more.
Semaglutide Fails to Slow Progression of Alzheimer Disease Compared to Placebo: Novo Nordisk Phase 3 Trial Update
Evoke trials testing semaglutide for Alzheimer disease missed primary endpoint, failing to demonstrate benefit on cognition despite positive effects on disease markers.
Bayer's Asundexian Reduces Ischemic Stroke Risk Without Raising Major Bleeding in Phase III Trial
Topline data show the factor XIa inhibitor cut ischemic stroke risk without increasing ISTH major bleeding, pointing to a possible new option for secondary prevention.